dilat
cardiomyopathi
dcm
preval
heart
muscl
diseas
character
impair
contractil
dilat
ventricl
recent
clinic
research
suggest
cardiotrop
virus
import
environment
pathogen
factor
human
dcm
may
therefor
consid
chronic
viral
cardiomyopathi
virusposit
dcm
patient
thu
come
focu
virolog
research
consid
antivir
strategi
therapi
shown
mediat
viru
elimin
patient
adenoviru
coxsackieviru
persist
discuss
sever
possibl
new
molecular
target
patient
infect
cardiotrop
virus
cellular
viru
uptak
system
virusinduc
cellular
signal
pathway
interact
virusencod
protein
import
cellular
target
protein
potenti
approach
set
chronic
viral
infect
significantli
differ
acut
viral
infect
specif
problem
encount
chronic
situat
possibl
solut
discuss
dilat
cardiomyopathi
dcm
preval
heart
muscl
diseas
character
impair
contractil
dilat
ventricl
chien
franz
et
al
recent
clinic
research
suggest
cardiotrop
virus
import
environment
pathogen
factor
human
dcm
may
thu
consid
chronic
viral
cardiomyopathi
bowl
et
al
et
al
et
al
pausching
et
al
b
et
al
frustaci
et
al
matsumori
et
al
matsumori
et
al
sinc
dcm
far
frequent
disord
acut
viral
cardiomyopathi
ie
classic
myocard
new
data
virus
dcm
heart
greatli
expand
number
patient
classifi
virusassoci
cardiac
diseas
patient
therefor
come
focu
virolog
research
may
consid
antivir
strategi
follow
review
discuss
sever
novel
therapeut
approach
deriv
broaden
perspect
virusassoci
cardiac
disord
clinic
endpoint
new
therapi
type
improv
symptom
surviv
et
al
cardiac
function
improv
may
expect
virusinfect
cardiac
cell
elimin
antivir
immun
respons
without
overshoot
inflamm
et
al
intracardiac
virus
function
silenc
sens
new
viru
particl
viral
genom
synthes
furthermor
transcript
activ
viral
genom
suppress
major
fraction
cardiac
cell
infect
silenc
may
prefer
immun
elimin
ie
destruct
infect
cell
de
novo
infect
cardiac
cell
viru
spread
within
heart
extracardiac
viru
pool
would
occur
blockad
process
receptor
level
may
use
possibl
new
molecular
target
achiev
goal
locat
cellular
viru
uptak
machineri
particular
heart
bergelson
et
al
gaggar
et
al
noutsia
et
al
fechner
et
al
et
al
virusinduc
cellular
signal
pathway
innat
immun
system
ulevitch
hertzog
et
al
interact
virusencod
protein
structur
function
import
target
cell
protein
rel
therapeut
potenti
target
discuss
consid
differ
acut
vs
chronic
diseas
phase
viral
disord
human
diseas
et
al
baboonian
et
al
vs
less
analog
anim
model
diseas
yanagawa
et
al
yanagawa
et
al
contrast
highli
special
anim
model
littl
known
far
human
kinet
cardiac
viru
load
possibl
migrat
within
heart
cardiac
eg
lymphat
cell
cellular
signal
pathway
activ
differ
cardiotrop
virus
detect
human
heart
certain
therapeut
strategi
suggest
cell
biolog
et
al
anim
studi
yanagawa
et
al
yanagawa
et
al
coxsackieviru
cardiomyopathi
may
possibl
also
work
human
cardiotrop
virus
recent
identifi
human
heart
eg
adv
et
al
adequ
anim
model
present
time
figur
provid
gener
overview
key
interact
site
virus
target
cell
known
cardiotrop
virus
taken
cell
receptormedi
endocytosi
bergelson
et
al
gaggar
et
al
noutsia
et
al
fechner
et
al
transport
nucleu
via
nuclear
pore
complex
receptor
level
thu
constitut
first
level
therapeut
target
fig
signific
de
novo
infect
cardiac
cell
viru
spread
within
heart
extracardiac
viru
pool
occur
therapeut
intervent
level
may
effect
acut
cardiac
viral
infect
may
caus
adv
also
et
al
rohayem
et
al
nigro
et
al
murri
et
al
often
fulmin
ultim
fatal
diseas
intervent
receptor
level
may
particular
therapeut
potenti
process
endocytosi
viral
genom
dna
rna
may
activ
signal
cascad
innat
antivir
immun
via
tolllik
receptor
tlr
one
hand
contribut
immunolog
elimin
virusinfect
cell
may
caus
damag
overshoot
immun
reaction
innat
immun
signal
thu
constitut
second
level
therapeut
target
fig
ulevitch
hertzog
et
al
optim
antivir
immun
respons
would
pinpoint
infect
cell
without
collater
damag
inadequ
inflamm
viru
elimin
solicit
interferon
inf
treatment
alreadi
shown
result
improv
cardiac
function
new
york
heart
associ
nyha
classif
human
et
al
even
immun
elimin
infect
cell
achiev
suppress
inflammatori
damag
coxsackievirusadenoviru
receptor
car
show
high
interindividu
variabl
human
heart
noutsia
et
al
fechner
et
al
littl
known
cardiac
express
known
receptor
cardiotrop
virus
tolllik
receptor
tlr
locat
membran
endosom
may
trigger
signal
cascad
innat
antivir
immun
depend
independ
tlr
tlrdepend
signal
pathway
form
second
level
therapeut
intervent
see
fig
knowledg
innat
immun
signal
molecul
human
heart
spars
viral
genom
transcrib
nucleu
translat
cytosol
product
may
act
upon
damag
structur
function
protein
cardiomyocyt
wherea
human
cardiotrop
virusencod
protein
data
interact
structur
function
protein
avail
dystrophin
shown
markedli
vulner
cleavag
enterovir
proteas
badorff
et
al
suppress
potenti
damag
virusencod
protein
may
therapeut
potenti
fig
modul
innat
immun
signal
may
use
chronic
infect
persist
overshoot
inflamm
maintain
chronic
signal
pathway
activ
chronic
phase
viral
cardiomyopathi
even
new
viru
particl
viral
genom
synthes
therefor
celltocel
viru
spread
possibl
occur
via
receptormedi
process
may
still
chronic
viral
transcript
activ
damag
host
cell
slow
insidi
process
may
go
unnot
clinician
unless
major
irrevers
cardiac
damag
occur
one
exampl
illustr
pathogen
principl
cleavag
cellular
dystrophin
enterovir
proteas
encod
badorff
et
al
xiong
et
al
protein
encod
cardiotrop
virus
may
also
damag
infect
heart
even
synthes
low
level
long
period
time
cardiacpersist
virus
fig
may
lead
insidi
decay
cardiac
function
proceed
unnot
unless
patient
regularli
care
monitor
silenc
respect
viral
gene
eg
rna
interfer
constitut
third
target
level
therapeut
intervent
intervent
type
silenc
strategi
may
protect
chronic
infect
heart
even
attempt
immun
elimin
virusinfect
cell
remain
unsuccess
cellular
viru
entri
celltocel
spread
within
heart
organtoorgan
migrat
within
host
via
circul
determin
viru
receptor
express
target
cell
viral
entri
pathway
human
heart
fulli
delin
induct
inhibit
pathway
would
decis
alter
individu
suscept
cardiac
viral
infect
induct
common
receptor
car
coxsackievirus
adenovirus
observ
human
dcm
cardiomyopathi
noutsia
et
al
fechner
et
al
receptor
induct
may
open
path
infect
receptordepend
virus
evadv
contribut
dual
infect
respect
virus
influenc
distinct
coreceptor
anoth
common
receptor
share
otherwis
unrel
virus
carindepend
group
b
adv
identifi
gaggar
et
al
current
unknown
genet
environment
factor
caus
dysregul
car
dcm
induct
may
critic
influenc
pathogenesi
sinc
viru
genom
preval
dcm
heart
genet
variant
viru
receptor
regulatori
pathway
could
provid
molecular
basi
import
genomeenviron
interact
influenc
diseas
process
therapeut
target
receptor
level
outlin
fig
may
expect
work
signific
de
novo
entri
viru
new
target
cell
celltocel
spread
within
heart
organtoorgan
migrat
within
host
via
circul
possibl
block
key
entri
mechan
high
effici
wherea
signific
viru
migrat
myocard
model
mice
littl
known
kinet
cardiotrop
virus
adv
cytomegaloviru
cmv
ebv
hcv
detect
human
chronic
viral
cardiomyopathi
et
al
necessari
better
character
kinet
decid
antireceptor
approach
may
applic
human
diseas
tool
current
avail
block
downregul
viru
receptor
antibodi
fusion
protein
direct
receptor
protein
andor
viru
epitop
involv
viru
bind
andor
intern
respect
bestcharacter
human
cardiotrop
viru
interest
recent
studi
use
solubl
recombin
decay
acceler
factor
daf
form
protein
yanagawa
et
al
analog
solubl
carfc
yanagawa
et
al
importantli
howev
approach
work
first
day
infect
priori
limit
possibl
use
human
case
acut
fulmin
myocard
signific
celltocel
migrat
occur
human
similar
situat
anim
model
antisens
decoy
oligonucleotid
yokoseki
et
al
success
employ
myocard
model
short
interf
rna
sirna
direct
mrna
encod
viru
receptor
use
eg
human
immunodefici
hiv
inhibit
zhou
et
al
transport
endosom
pathway
rna
dna
viral
genom
might
engag
certain
tlr
link
key
signal
cascad
innat
immun
ulevitch
genet
alter
immun
pathway
decis
alter
diseas
cours
viral
infect
thu
mortal
infect
low
mice
lack
key
compon
tlrdepend
innat
immun
signal
compar
wildtyp
anim
mice
protect
myocard
genetarget
knockout
src
famili
kinas
essenti
cell
activ
liu
et
al
contrast
infect
mice
result
excess
mortal
compar
control
deonarain
et
al
extracellular
signalregul
kinas
intens
heart
myocarditissuscept
aj
mice
contrast
myocarditisresist
mice
respons
may
thu
contribut
differenti
host
suscept
opavski
et
al
rat
experiment
autoimmun
myocard
decoy
oligonucleotid
nuclear
factor
nf
highli
effici
develop
diseas
yokoseki
et
al
knowledg
far
analog
studi
viral
heart
diseas
publish
therapeut
target
virusactiv
signal
cascad
innat
immun
outlin
fig
may
deriv
recent
work
genet
knockout
anim
infect
analog
improv
surviv
upon
infect
see
chap
volum
knockout
anim
liu
et
al
suppress
respect
gene
sirnamedi
rna
interfer
investig
respect
therapeut
potenti
sinc
key
point
innat
immun
signal
suppress
sirna
small
molecul
drug
inhibit
function
may
highli
effici
inappropri
overshoot
inflammatori
reaction
heart
accompani
antivir
respons
analysi
import
immun
signal
molecul
virusinfect
human
heart
seem
worthwhil
sinc
recent
anim
data
suggest
high
therapeut
potenti
current
unknown
chronic
human
viral
cardiomyopathi
similar
innat
immun
signal
pathway
target
specif
anim
model
relev
virus
encount
chronic
human
viral
cardiomyopathi
far
frequent
eg
kinet
chronic
human
diseas
grossli
differ
anim
model
therefor
interest
investig
cardiac
express
profil
base
human
cardiac
biopsi
viru
induc
specif
alter
innat
immun
signal
common
pattern
across
mani
differ
viru
speci
latter
case
approach
direct
innat
immun
may
becom
therapeut
relev
larg
number
patient
beyond
protein
involv
cellular
viru
entri
antivir
defens
sever
structur
protein
cardiomyocyt
build
sarcomer
sarcolemma
cytoskeleton
zband
intermedi
filament
known
mutat
case
famili
dcm
franz
et
al
populationwid
comprehens
mutat
scan
far
publish
gene
thu
full
extent
genet
variabl
unknown
howev
one
pioneer
experiment
studi
alreadi
demonstr
extent
mutat
may
aggrav
cardiac
damag
caus
viru
led
grossli
aggrav
diseas
dystrophindefici
mice
badorff
et
al
xiong
et
al
enterovir
proteas
cleav
cellular
structur
protein
dystrophin
dystrophindefici
anim
also
normal
anim
although
lesser
extent
probabl
systemat
search
cellular
site
vulner
attack
protein
encod
human
cardiotrop
virus
reveal
therapeut
target
protect
respect
vulner
cellular
protein
may
principl
achiev
sirnamedi
suppress
respect
viral
gene
specif
develop
smallmolecul
drug
wherea
labori
develop
smallmolecul
drug
block
relev
virusencod
protein
interact
site
cellular
protein
must
done
everi
individu
relev
protein
applic
rna
interfer
sirna
gener
approach
alreadi
success
employ
number
differ
virus
vitro
vivo
zhou
et
al
stevenson
ping
et
al
dave
pomerantz
gao
et
al
zhang
et
al
bhuyan
et
al
takigawa
et
al
kameoka
et
al
wang
et
al
lu
et
al
li
et
al
includ
recent
studi
schubert
et
al
yoon
et
al
cmv
inhibit
vitro
wiebusch
et
al
one
possibl
problem
sirna
therapi
vivo
effici
transfer
sirna
target
cell
recent
adenoassoci
viru
aav
vector
express
sirna
special
express
cassett
success
use
variou
purpos
pinkenburg
et
al
grimm
et
al
michel
et
al
xia
et
al
far
current
understand
chronic
cardiac
viral
infect
human
therapeut
strategi
inhibit
cellular
viru
uptak
migrat
may
work
signific
celltocel
traffic
via
receptormedi
endocytosi
pathogen
viru
still
occur
chronic
phase
present
know
eg
cardiac
reinfect
extracellular
pool
intracardiac
viru
spread
occur
chronic
diseas
human
clinic
studi
solv
question
warrant
modul
maladapt
innat
immun
signal
ii
highli
effici
anim
model
studi
respect
signal
pathway
human
perform
sinc
approach
may
possibl
work
across
differ
viru
speci
thu
provid
new
gener
therapeut
principl
final
silenc
iii
virus
persist
cardiac
cell
low
transcript
activ
long
period
time
may
inhibit
insidi
damag
heart
observ
eg
virusposit
dcm
futur
molecular
studi
cardiotrop
virus
identifi
virusencod
protein
damag
key
cellular
protein
cardiomyocyt
endotheli
cell
approach
may
gain
major
import
gener
wellcharacter
anim
model
wherea
lack
anim
model
cardiotrop
virus
data
kinet
chronic
cardiac
viral
diseas
human
clinic
anim
studi
address
latter
issu
warrant
sinc
shall
provid
basi
develop
improv
therapi
